drug recalls

Affymax, Takeda Recall Anemia Drug Omontys After Deaths

U.S.-based Affymax Inc and Japan's Takeda Pharmaceutical Co said they are voluntarily recalling all lots of anemia treatment Omontys (peginesatide) in the United States due to reports of serious hypersensitivity reactions, including some deaths.

Johnson & Johnson Recalls Tylenol Products on Odor Complaints

Johnson & Johnson (JNJ) is recalling Tylenol products because of a musty odor, the company%u2019s third such recall in 12 months. J&J is yanking a line of Tylenol 8-hour caplets containing 127,728 bottles after customers complained of a musty smell from the pills, Bloomberg News said. The smell may be related to a chemical that is applied to wooden pallets used to store packing materials.

Amgen, J&J Recall Procrit, Epogen for Possible Glass Issue

Drug-makers Amgen and Johnson & Johnson are voluntarily recalling two brands of an injectable anemia medication because of the possibility that vials of it may also contain tiny glass flakes. The drug, Epoetin alfa, is marketed under the brand names Epogen and Procrit.

FDA Sends J&J Warning Letter on Two Products

In a warning letter to J&J's DePuy Orthopaedics, the FDA says it is illegally marketing its TruMatch CT scanner and Corail Hip System. This is the latest in a series of problems at J&J, which include a big children's Tylenol recall.

J&J Recall Hearing: Contradictions and Cover-Ups

At Congress' hearings on Johnson & Johnson's huge recall of Children's Tylenol, among other drugs, the company's statements were contradicted by the Food and Drug Administration, and details of J&J's Motrin "phantom recall" were revealed.